Related Experiment Video
Updated: Aug 13, 2026

Direct Induction of Human Neural Stem Cells from Peripheral Blood Hematopoietic Progenitor Cells
Published on: January 28, 2015
Pediatric large volume peripheral blood progenitor cell collections from patients under 25 kg: a primer
J B Gorlin1, D Humphreys, P Kent
1Department of Nursing, Children's Hospital, Boston, Massachusetts 02115, USA.
Insights
Peripheral blood progenitor cell collection in small pediatric patients presents unique challenges. This study demonstrates safe and effective large-volume collections in children under 25 kg, yielding significant progenitor cells.
Area of Science:
- Pediatric Hematology
- Cellular Therapy
- Medical Device Technology
Background:
- Collecting peripheral blood progenitor cells (PBPCs) from pediatric patients poses distinct technical and social challenges compared to adults.
- Small patients (<25 kg) require specialized approaches for venous access, anticoagulation, and managing extracorporeal volume ratios.
Purpose of the Study:
- To report on the experience of a single institution performing large-volume PBPC collections in pediatric patients weighing less than 25 kg.
- To analyze the specific challenges and outcomes associated with PBPC collection in this vulnerable population.
Main Methods:
- Retrospective analysis of 85 PBPC collections from 14 pediatric patients (<25 kg) over two years.
- Utilized central venous catheters (CVCs) for access, systemic heparinization with activated clotting time (ACT) monitoring, and citrate anticoagulation.
- Employed a COBE Spectra apheresis system with modified priming and processing protocols to optimize for small patients.
Main Results:
- Achieved a median yield of 4.5 x 10^6/kg CD34+ cells per collection.
- Central venous catheters (7-10 Fr) were uniformly required for venous access.
- Identified and enumerated complications, primarily related to catheter access.
Conclusions:
- Large-volume PBPC collection is feasible and effective in small pediatric patients.
- Careful management of anticoagulation, extracorporeal volume, and venous access is crucial for successful collections.
- The study highlights the importance of addressing both technical and social aspects for optimal pediatric apheresis outcomes.
Abstract:
Collection of peripheral blood progenitor cells from small pediatric patients provides many social and technical challenges not faced when collecting from adult patients. This paper provides a single institutions experience with 85 collections from 14 patients less than 25 kg of weight over a 2 year period. Specific challenges include obtaining venous access, anticoagulation, volume shifts, and obtaining patient cooperation. A systematic analysis of options for access, alternative modes of anticoagulation, and the effect of large ratios of extra-corporeal volume to patient's blood volume are discussed. Access uniformly required central venous catheters (CVC) ranging from 7-10 Fr. Anticoagulation included systemic heparinization titrating dose by activated clotting time in all cases and combined with citrate at a ratio of 1:25-1:30 in most cases. Collections were performed on a COBE Spectra, after priming with leukoreduced irradiated red cells and omitting both the initial 120cc diversion and rinse back of red cells at the end. Social challenges include issues of assent and ability to distract patients for the duration of a prolonged collection. Progenitor yields from collections from 14 patients were quantitated by CD34+ assay in all cases and CFU-GM in ten of 14 patients. A median of 4.5 x 10(6)/kg CD34+ cells were obtained for each collection. Complications, including those related to catheter access, are enumerated. In summary, large volume peripheral blood progenitor collection can be safely and efficaciously performed in small pediatric patients.
More Related Videos
10:25Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021